Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome

OBJECTIVES: The aim of the study is to compare surrogate markers of cardiovascular disease (CVD) risk, such as adiponectin (APN) levels and low-density lipoprotein (LDL) size, before and after sustained release metformin (Met-SR) therapy in women with polycystic ovarian syndrome (PCOS). METHODS: Six...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, D. Rama Nagendra, Seshadri, Krishna G., Pandurangi, Monna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628535/
https://www.ncbi.nlm.nih.gov/pubmed/28989873
http://dx.doi.org/10.4103/ijem.IJEM_154_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628535/
https://www.ncbi.nlm.nih.gov/pubmed/28989873
http://dx.doi.org/10.4103/ijem.IJEM_154_17

Ejemplares similares